161 related articles for article (PubMed ID: 9708505)
1. Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome.
Kao CH; Ho YJ; Lan JL; ChangLai SP; Chieng PU
J Nucl Med; 1998 Aug; 39(8):1354-6. PubMed ID: 9708505
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome.
Kao CH; Lan JL; ChangLai SP; Chieng PU
J Nucl Med; 1998 May; 39(5):773-7. PubMed ID: 9591573
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
4. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
5. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain--a preliminary report.
Huang WS; Chiu PY; Kao A; Tsai CH; Lee CC
Rheumatol Int; 2003 Jul; 23(4):174-7. PubMed ID: 12856142
[TBL] [Abstract][Full Text] [Related]
6. Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging.
Chang CP; Shiau YC; Wang JJ; Ho ST; Kao A
Ann Rheum Dis; 2002 Sep; 61(9):774-8. PubMed ID: 12176800
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-HMPAO SPECT and MRI of brain in patients with neuro-Behçet's syndrome.
Kao CH; Lan JL; ChangLai SP; Chieng PU
J Nucl Med; 1998 Oct; 39(10):1707-10. PubMed ID: 9776273
[TBL] [Abstract][Full Text] [Related]
8. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET.
Lass P; Krajka-Lauer J; Homziuk M; Iwaszkiewicz-Bilikiewicz B; Koseda M; Hebanowski M; Lyczak P
Nucl Med Commun; 2000 Jan; 21(1):31-5. PubMed ID: 10717899
[TBL] [Abstract][Full Text] [Related]
9. Discordance between FDG uptake and technetium-99m-HMPAO brain perfusion in acute traumatic brain injury.
Abu-Judeh HH; Singh M; Masdeu JC; Abdel-Dayem HM
J Nucl Med; 1998 Aug; 39(8):1357-9. PubMed ID: 9708506
[TBL] [Abstract][Full Text] [Related]
10. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT.
Belin C; Moroni C; Caillat-Vigneron N; Debray M; Baudin M; Dumas JL; Moretti JL; Delaporte P; Guillevin L
Ann Med Interne (Paris); 1999 Dec; 150(8):598-604. PubMed ID: 10686641
[TBL] [Abstract][Full Text] [Related]
12. Disparity of perfusion and glucose metabolism of epileptogenic zones in temporal lobe epilepsy demonstrated by SPM/SPAM analysis on 15O water PET, [18F]FDG-PET, and [99mTc]-HMPAO SPECT.
Lee DS; Lee JS; Kang KW; Jang MJ; Lee SK; Chung JK; Lee MC
Epilepsia; 2001 Dec; 42(12):1515-22. PubMed ID: 11879361
[TBL] [Abstract][Full Text] [Related]
13. Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy.
Sabri O; Hellwig D; Schreckenberger M; Cremerius U; Schneider R; Kaiser HJ; Doherty C; Mull M; Ringelstein EB; Buell U
J Nucl Med; 1998 Jan; 39(1):147-54. PubMed ID: 9443754
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome.
Kao CH; Lan JL; Hsieh JF; Ho YJ; ChangLai SP; Lee JK; Ding HJ
J Nucl Med; 1999 Sep; 40(9):1446-50. PubMed ID: 10492363
[TBL] [Abstract][Full Text] [Related]
15. Functional imaging in periventricular nodular heterotopia with the use of FDG-PET and HMPAO-SPECT.
Morioka T; Nishio S; Sasaki M; Yoshida T; Kuwabara Y; Ohta M; Fukui M
Neurosurg Rev; 1999; 22(1):41-4. PubMed ID: 10348206
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging in schizencephaly using [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime (HMPAO-SPECT).
Morioka T; Nishio S; Sasaki M; Yoshida T; Kuwabara Y; Nagamatsu T; Fukui M
Neurosurg Rev; 1999 Oct; 22(2-3):99-101. PubMed ID: 10547006
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-HMPAO brain SPECT in Behçet's disease.
García-Burillo A; Castell J; Fraile M; Jacas C; Vilardell M; Ortega D; Bosch JA
J Nucl Med; 1998 Jun; 39(6):950-4. PubMed ID: 9627324
[TBL] [Abstract][Full Text] [Related]
18. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
[TBL] [Abstract][Full Text] [Related]
19. Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.
Sun SS; Liu FY; Tsai JJ; Yen RF; Kao CH; Huang WS
Rheumatol Int; 2003 Nov; 23(6):301-4. PubMed ID: 12684837
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
Lin WY; Wang SJ; Yen TC; Lan JL
J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
